Back to Treatments

Treatment

Carboplatin + Paclitaxel

1
Conditions
347
Trials
50K
Participants
30%
Average Safety

Condition Evidence

Ovarian cancer

347 trials · 50K participants

75% effectiveness · 30% safety
Carboplatin + Paclitaxel | DFDA